Atea Pharmaceuticals AVIR
NASDAQ AVIR
$4.27 -0.20 (-4.37%)
As of: Oct 21, 2026 · 1:51 PM EDT

Atea Pharmaceuticals (AVIR) Capital Expenditures (2020 - 2022)

Updated

Atea Pharmaceuticals' Capital Expenditures was $1.94 million in FY2022, compared with $4,000 in FY2021.

Analysis

Atea Pharmaceuticals (AVIR) Capital Expenditures (2020 - 2022) Analysis & Trends

From FY2018 onward, Atea Pharmaceuticals has reported Capital Expenditures for 5 years.

  • Capital Expenditures shows a four-year compound annual growth rate of 256.7% (FY2018 to FY2022).
  • The FY2022 figure marks the highest annual Capital Expenditures in data going back to FY2018.
  • Per Business Quant data, Capital Expenditures in earlier years was $4,000 in FY2021 (-84.6%), $26,000 in FY2020, $2,000 in FY2019 (-83.3%) and $12,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn 1.32 Bn
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn 322.00 Mn
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 1.86 Bn
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn 140.00 Mn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn 533.00 Mn
10 Atea Pharmaceuticals 341.82 Mn -764.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 20,000.00
Jun 30, 2022 1.88 Mn
Mar 31, 2022 44,000.00
Dec 31, 2020 5,000.00
Sep 30, 2020 15,000.00
API Access

Atea Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AVIR&period=max&api_key=YOUR_API_KEY